4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-053560
EVP, Research & CSO sold 2,750 shares at $50.00 ($137,500)
- EVP, Research & CSO acquired 2,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-08-25 | Option exercise | +2,750 | $1.53 | $4,208 | 102,450 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2021-08-25 | Sale | −2,750 | $50.00 | $137,500 | 99,700 | D: show line 2 in the form |
| Open-market sales · 2,750 sh · avg $50.00 · $137,500 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-08-25 | Option exercise · Stock Option (Right to Buy) | −2,750 | 267,380 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…